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Abstract
Background: Embryonic stem cells are intrinsically unstable and differentiate spontaneously if they are not shielded
from external stimuli. Although the nature of such instability is still controversial, growing evidence suggests that
protein translation control may play a crucial role.
Results: We performed an integrated analysis of RNA and proteins at the transition between naïve embryonic stem
cells and cells primed to differentiate. During this transition, mRNAs coding for chromatin regulators are specifically
released from translational inhibition mediated by RNA-induced silencing complex (RISC). This suggests that, prior
to differentiation, the propensity of embryonic stem cells to change their epigenetic status is hampered by RNA
interference. The expression of these chromatin regulators is reinstated following acute inactivation of RISC and it
correlates with loss of stemness markers and activation of early cell differentiation markers in treated embryonic
stem cells.
Conclusions: We propose that RISC-mediated inhibition of specific sets of chromatin regulators is a primary
mechanism for preserving embryonic stem cell pluripotency while inhibiting the onset of embryonic
developmental programs.
Background
Embryonic stem (ES) cells tend to spontaneously differ-
entiate in the absence of external inductive signals [1].
The first step of ES cell differentiation, commonly re-
ported as “priming”, is mostly associated with changes in
the dynamics of chromatin, post-translational modifica-
tions of histones, and a general remodeling of nuclear
architecture [2]. Priming is considered necessary for
lineage specification in the early embryo but the exact
mechanisms mediating its action on the transition from
pluripotency state to the differentiation of embryonic tis-
sues are not understood. Inhibition of protein transla-
tional noise [3] and transcriptional “leakage” [4, 5]
characterize mouse ES cells. This indicates that lineage
specification during early embryonic development could
be driven by reduction of the transcribed portion of the
genome but it also poses the question of how pluripo-
tency can accommodate the transcription of tissue-
specific genes.
We speculated that a tight inhibitory control of trans-
lation is crucial to maintain pluripotency and that inhib-
ition of protein translation through microRNA (miRNA)
and the RNA-induced silencing complex (RISC) [6]
might represent one strategy to avoid a “transcriptional
paradox”. There is, indeed, an established body of evi-
dence indicating that release from RISC-mediated trans-
lational inhibition, produced through the disruption of
components of the miRNA maturation pathway such as
Dicer [7] or DGCR8 [8], severely impairs pluripotency in
ES cells. This observation implies that inhibition of pro-
tein translation is necessary for pluripotency. However,
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while the general involvement of RISC is established, lit-
tle is known about the families of genes subject to this
control. In our investigation, we found that a set of
mRNAs encoding chromatin regulators is selectively
released from miRNA-mediated protein translation
inhibition during priming and we conclude that their in-
hibition is crucial for the maintenance of ground state
pluripotency.
Results
Epiblast-like aggregate cells are equivalent to primed
pluripotent cells
To address the role of RISC in ES cell differentiation, we
employed a protocol of mouse ES cell neuralization that
reproduces the main steps of early embryonic neural de-
velopment [9] (see “Methods”). Cells at 2, 6, 10, and
13 days of in vitro differentiation (DIV) correspond to
epiblast-like aggregates (ELA), neural progenitor cells
(NPC), neural precursors (NPC/Neu) and differentiated
neurons (Neu), respectively (Fig. 1a). To establish the
identity of ELA cells, we focused on gene expression
changes at the ES–ELA transition. General markers of
pluripotency, Oct4 and Sox2, were only marginally af-
fected during the ES–ELA transition (Fig. 1b), indicating
an undifferentiated condition. However, epiblast markers
fibroblast growth factor (FGF)5 [10] and eomesodermin
[11] were up-regulated. FGF4, Klf4, Rex1, Esrrb, and
Dax1, which are markers of ground-state pluripotency
[12, 13], and Nanog were highly down-regulated
(Fig. 2b–d). This is similar to what is observed in post-
implantation epiblast stage embryos [14] or in mouse ES
cell (mESC)-derived epiblast stem cells (EpiSC) [15]. To
further investigate this, we performed a more detailed
analysis of Nanog expression. The distribution of green
fluorescent protein (GFP) intensity of a TNG-A
Nanog::GFP ES cell line [16], while shifting from high to
low level during the ES–ELA transition, maintains a nar-
row peak and is almost superimposable on the distribu-
tion of GFP intensity during the ES–EpiSC transition
(Fig. 2e); this indicates that the ES–ELA transition
occurs in a quite homogeneous fashion and suggests that
ELA cells might be equivalent to post-implantation epi-
blast cells.
Mouse EpiSC can be maintained in a pluripotent state
similar to that of human ES cells (hESCs) [17, 18] by
FGF2/Activin A treatment [12, 13]. Ground-state mESC
cultured for several passages in FGF2/Activin-containing
medium (Fig. 2f ) acquire a flattened morphology (Fig. 2h)
and retain a gene expression profile similar to ELA cells
and consistent with epiblast identity [15, 19]. Accord-
ingly, ELA-derived cells could be dissociated and main-
tained in an EpiSC-like state by adding FGF2/Activin A
to culture medium (Fig. 2g). The resulting cells (ELA-
EpiSC; Fig. 2i) displayed a high level of correlation with
the gene expression profile of mESC-derived EpiSC
(Fig. 2j, k).
As well as ground-state mESC, pluripotent stem cells
derived from the epiblast spontaneously neuralize when
deprived of FGF2 and Activin A. Similarly, more than
90 % of ELA-EpiSC induced the early marker of neurali-
zation Sox1 72 h after FGF2/Activin A withdrawal
(Fig. 2l). These cells became nestin-positive neural pro-
genitor cells (Fig. 2m) and differentiating neurons posi-
tive to N-tubulin and Pax6 (Fig. 2n) by down-regulating
Oct4 and Nanog and up-regulating neuronal differenti-
ation markers (Nestin, β-III-tubulin and NFL; Fig. 2o).
These results thus indicate that ELA cells can be con-
sidered to be equivalent to epiblast stem cells and, there-
fore, the ES–ELA transition could be used as an in vitro
model of the transition from inner mass cells to primed
post-implantation epiblast cells. Using ELA instead of
EpiSC allows the requirement for exogenous FGF and
Activin to be avoided, whose action could not parallel
the autocrine signaling of the developing embryo. More-
over, since ELA cells are not steady-state cultures as
EpiSC are, they retain the transient nature of epiblast
cells in vitro and provide a better model than EpiSC
for studying spontaneous, rapidly occurring molecular
changes during this developmental transition.
Profiling of Argonaute occupancy at early steps of ES cell
differentiation
We performed a global survey of the mRNAs that interact
with Argonaute (Ago) during the first stages of in vitro
differentiation. Towards this goal, we isolated Ago-
interacting RNAs by immunoprecipitating Ago proteins
(Ago* in Additional file 1: Figure S1a), which are the main
RISC components [6]. Ago–RNA and total RNA from
cells at 0, 2, 6, and 10 DIV were hybridized to gene ex-
pression microarrays (Fig 2a). The release of mRNA from
Ago at the transition between sequential steps was evalu-
ated as the variation of the ratio between Ago–RNA and
total RNA levels after normalization (Ago Enrichment in
Additional file 1: Figure S1b, c; Additional file 2: Table S1;
see “Methods”). While most of the transcriptional regula-
tion occurred at the ELA–NPC transition (Fig. 2b), the
highest release of mRNA by Ago was observed at the ES–
ELA transition (Fig. 2c), with more than 100 mRNA spe-
cies significantly released from Ago binding. We verified
that this could not be explained by either different
efficiency in Ago immunoprecipitation (Additional file 1:
Figure S1a) or differential expression of Ago- or miRNA-
related genes in the two conditions (Additional file 1:
Figure S1d). The variation in Ago enrichment was co-
herently correlated with the variation in total RNA
level at the ES–ELA transition for 82.4 % of genes
(Additional file 1: Figure S1e), confirming a predom-
inant effect of RISC on mRNA destabilization [20].
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Fig. 1 (See legend on next page.)
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mRNAs of selected chromatin regulator families are
preferentially released by Ago during the ES–ELA
transition
We investigated the nature of the mRNAs released by
Ago during priming by analyzing the distribution of
Gene Ontology (GO) terms in our Ago RNA immuno-
precipitation (Ago-RIP) results. Genes whose mRNAs
were mainly associated with Ago in ES cells belong to
gene ontologies related to DNA repair, replication, chro-
matin organization and modification, and embryonic de-
velopment (Fig. 3a; Additional file 3: Table S2). The
release by Ago of mRNAs involved in DNA repair and
replication in ELA cells is consistent with the marked
enhancement of replication observed in epiblasts follow-
ing implantation [21].
Chromatin modifications are postulated to play a
crucial role in priming [22–24] but miRNA-mediated
translational control of chromatin regulators has never
been extensively described. Therefore, we focused our
attention on the release by Ago of distinct families of
chromatin modifiers [25] (Additional file 3: Table S2).
While the families of mRNAs coding for de novo DNA
methyltransferases (DNMT), histone lysine demethylases
(KDM), and SWItch/Sucrose NonFermentable nucleo-
some remodeling complex (SWI/SNF) showed a more
than twofold increase of Ago enrichment in ES cells com-
pared with ELA cells, other families of chromatin regula-
tors showed little or no increase, similar to what was
observed for families of mRNAs with unrelated functions
such as cytochrome P450 (CYP450; Fig. 3c).
Ago enrichment is predictive of protein translation activity
To detect changes in protein translation at the ES–ELA
transition, we evaluated ribosome occupancy by means
Fig. 2 a ES cell in vitro neuralization and RNA analysis. DIV days of in vitro differentiation. b The fraction of total mRNAs that are up- or down-
regulated between consecutive steps of differentiation, with a threshold of |log2FC| > 2.5 (where FC is fold change). c Number of genes whose
mRNA is significantly released (or loaded) by Argonaute (Ago; see “Methods”); ***p = 0.001 (χ2-test). IP immunoprecipitation
(See figure on previous page.)
Fig. 1 a ES cell in vitro neuralization. DIV days of in vitro differentiation. 0DIV corresponds to the time of leukemia inhibitory factor (LIF) withdrawal.
N2 and B27 are the supplements used in the minimal medium of differentiation. Example of bright-field microphotographs of cells at different DIV are
shown on the bottom. ELA epiblast-like aggregates, NPC neural progenitor cells, NPC/Neu neural precursors, Neu differentiated neurons. b RT-PCR gene
expression analysis. Values are relative to β-actin mRNA expression. Highest and lowest expression levels were normalized to 1 in the left/
middle histograms and in the right histogram, respectively. c, d Oct4 and Nanog immunodetection in ES cells (c) or ELA cells (d). e Violin
plot shows the distribution of green fluorescent protein (GFP) intensity in a TNG-A Nanog::GFP line [16] in LIF/serum (ES cells, red) and 24 h (green) or
48 h (blue) after LIF/serum withdrawal (ELA) or Activin/fibroblast growth factor (FGF)2 induction (EpiSC), respectively. f, g Derivation of epiblast stem
cells (EpiSC) and ELA-EpiSC from ES and ELA cells, respectively. h, i EpiSC and ELA-EpiSC bright-field images. j Expression correlation of
markers of pluripotency and priming between EpiSC (y-axis) and ELA-EpiSC (x-axis). Values are expressed as log2ΔCt of RT-PCR assay;
R2 coefficient of determination. k Hierarchical clustering analysis on Spearman correlation between different microarray samples. l Flow
cytofluorimetric analysis of Sox1::GFP cells (46C line), indicating the ratio of GFP-positive cells (y-axis) in different cell types or times of
differentiation (x-axis). m, n Immunodetection of neural markers at 7 days of ELA-EpiSC neuralization. o RT-PCR gene expression analysis
as in b in ELA-EpiSC after 4 (+4DIV) or 8 (+8DIV) days from FGF2/Activin A withdrawal. Error bars in b, l, and o show standard error. In b and
o *p = 0.05, **p = 0.01 (REST randomization test). Scale bars are 30 microns in a, c, and d, 40 microns in h, i, m, and n
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of polysome profiling [26, 27] (see “Methods”; Additional
file 1: Figure S2a, b), adapting the translating ribosome
affinity purification (TRAP) protocol for our purposes.
We measured the amount of mRNAs loaded on translat-
ing ribosomes and calculated ribosome enrichment as an
estimate of ribosome occupancy. Our analysis showed
that the GO categories of genes showing increased ribo-
some loading during the ES–ELA transition were almost
superimposable on those found for genes released from
Ago (Fig. 3a, b). Strikingly, DNMT, KDM, and SWI/SNF
families showed a ribosome enrichment essentially recip-
rocal to their Ago enrichment (Fig. 3d).
To further verify our findings, we carried out label-
free mass spectrometry (MS) of protein nuclear extracts.
Notably, we observed a general correspondence of pro-
tein level variation with both Ago-RIP and polysome
profiling data (Fig. 4a). This observation indicates that
our method of evaluation of Ago enrichment is quite
predictive of protein translation inhibition. Using MS, we
identified two DNMT members (Dnmt1 and Dnmt3b),
Fig. 3 a GO terms significantly enriched in both gene sets of mRNAs released from Ago (Ago-RIP, gray) and of mRNAs significantly loaded on
ribosomes (Polysome profiling, dark blue) at the ES–ELA transition, as obtained by DAVID (see “Methods”). Fold enrichment bars are grouped
according to DNA replication, chromatin regulation, and embryonic development terms; a complete list of all enriched terms in each subset is
provided in Additional file 3: Table S2. b Distribution of log2 ribosome enrichment variation (RiboΔE) during the ES–ELA transition. c, d Box plots
of Ago enrichment (c) and log2 ribosome enrichment (Ribo Enrichment) (d) of mRNAs belonging to distinct classes of chromatin regulators, as
listed in Histome [25] (for a complete list of genes taken into account see also Additional file 3: Table S2). In red, families showing statistically
significant differences in enrichment. HAT histone acetyl-transferases, HDAC histone deacetylases, HMT histone methyl-transferases, PRC1/2 Polycomb
repressor complex 1/2. *p = 0.05, **p = 0.01, ***p = 0.001 (Wilcoxon test)
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two KDM members (Kdm2b and Kdm5b), and three
SWI/SNF members (Chd4, SmarcA4, and SmarcD1) as
significantly increased during the transition to ELA
(Additional file 4: Table S3). In all these cases, the increase
in overall mRNA level was modest, strongly indicating a
post-transcriptional effect (Fig. 4b–d). Dnmt3b, SmarcA4,
and Kdm2b proteins were barely detectable in the cyto-
plasm of ES cells (Additional file 1: Figure S2E), arguing
Fig. 4 a Upper panel: the distribution of Ago enrichment variation (ΔE) during the ES–ELA transition. The most negative side of the x-axis (ΔE < −5),
containing few values (density < −0.002), is not shown for clarity (for comparison, see Additional file 1: Figure S1e). Middle and lower panels:
comparison between log2 variation of ribosome enrichment (RiboΔE, middle panel) or log10 protein fold changes (lower panel) of three
subsets of genes displaying significant Ago release (ΔE ≤ −2, green), significant Ago loading (ΔE ≥ 2, pink) or non-significant change of Ago
enrichment (−1 ≤ ΔE ≤ 1, gray). Asterisks indicate the p value (Student’s t-test, ***p = 0.001) against the null hypothesis of mean equal to 0.
b–d Total mRNA fold change (Tot mRNA), linear Ago enrichment (Ago En), ribosome enrichment (Ribo En), and MS fold change (Protein) for
the members of DNMT, KDM, and SWI/SNF classes of chromatin regulators detected in ES and ELA nuclear cell extracts. The plus sign marks
values that are slightly out of the ranges indicated in “Methods” but are still relevant. Other genes unrelated to these families but displaying
similar regulation are listed in Additional file 4: Table S3. **p = 0.01, ***p = 0.001 (Wilcoxon test). Error bars show standard error
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against a switch in cytoplasmic to nuclear localization as
an explanation for the protein changes observed. Indeed,
this phenomenon could most likely be explained by the
dramatic drop in Ago enrichment displayed by these spe-
cific mRNA families during the ES–ELA cell transition.
Furthermore, it would likely not be due to a general drop
in RISC activity as the bulk of variation of Ago enrich-
ment is symmetrical and zero-centered (Fig. 4a, upper
panel). Intriguingly, the modest increase in total mRNA
levels suggests either that these specific mRNAs undergo
a lower RISC-mediated decay than that of the majority of
Ago-loaded mRNAs (see above) or that an additional tran-
scriptional modulation is occurring.
DNMT, KDM, and SWI/SNF activities are necessary to
switch between ground and primed pluripotent cell
states
We assayed the impact of the functional inhibition of
chromatin regulators on the expression of Nanog, which
is down-regulated during priming [28]. Using the mouse
TNG-A Nanog::GFP line [16] as a model, we inhibited
our target genes using either drugs, 5-azacytidine (AZA)
[29] for DMNT and 5-carboxy-8-hydroxyquinoline
(CHQ) [30] for KDM, or lentiviral-mediated transduc-
tion of short hairpin RNAs (shRNA) against SmarcA4
(shSA4) and measured the effect on Nanog expression at
0, 2, or 4 DIV (Fig. 5a, b; Additional file 1: Figure S3a–c).
AZA, CHQ, and shSA4 significantly increased the ratio of
GFP-positive cells at 4 DIV compared with control
(Fig. 5b), maintaining a high median content of fluores-
cence (Additional file 1: Figure S3c). A similar analysis
was performed using a mESC line carrying GFP under the
control of the human Nanog promoter (HNP; Additional
file 1: Figure S3d–g). This analysis produced similar re-
sults (Fig. 5c,d; Additional file 1: Figure S3c), suggesting
that DNMT, KDM, and SWI/SNF activity is necessary for
human Nanog down-regulation during priming and that
such a requirement might have been conserved in mice
and humans. In addition to Nanog, markers of pluripo-
tency such as Klf4, Rex1, and Dax1 were up-regulated in
cells treated with AZA, CHQ, or shSA4 compared with
control at 4 DIV, while the priming marker Fgf5 was
down-regulated (Fig. 5e, f ).
We investigated the role of DNMT in silencing Nanog
expression more directly by monitoring Nanog promoter
methylation, which was consistently inhibited by AZA
treatment at 2 DIV compared with control (Fig. 5g).
Interestingly, CHQ treatment and shSA4 transduction
blocked the methylation of the Nanog promoter as well
(Fig. 5g), indicating the requirement of KDM and
SWI/SNF activities in this modification, in agreement
with previous reports [31]. At 2 DIV, cells treated
with AZA and CHQ showed a global mRNA expres-
sion profile almost identical to that of ES cells, as
evaluated by hierarchical clustering and fold change
analysis (Additional file 1: Figure S3h–n). Cells transduced
with shSA4 showed a modulation of their profile con-
sistent with that of AZA and CHQ (Additional file 1:
Figure S3l) but, in this case, gene expression clustered
with that of ELA cells (Additional file 1: Figure S3h),
suggesting that the combined action of several SWI/
SNF members might be necessary to control the ES–
ELA cell transition.
RISC inactivation de-represses the translation of selected
chromatin regulators and destabilizes pluripotency
In order to evaluate the impact of global miRNA activity
in ES cells, we performed acute RISC functional in-
activation. We used a CRISPR/Cas9 lentivector (see
“Methods”) with an RNA guide targeting both Ago1
and 2 (Fig. 6a, b; Additional file 1: Figure S4b), which
are the only Argonaute genes expressed in ES cells
(Additional file 1: Figure S4a). RISC down-regulation
resulted in a dramatic increase in Dnmt3b, SmarcA4,
and Kdm2b protein levels (Fig. 6c) without signifi-
cantly affecting their mRNA (Fig. 6d). This increase
in protein level was also observed when the mTOR
pathway or the protein degradation pathway were
pharmacologically inhibited, although to a lower extent
due to the general decrease/increase in protein levels
(Additional file 1: Figure S4c). This indicates that RISC-
mediated control of these proteins occurs and is inde-
pendent from their rate of translation/degradation. In
addition, RISC inactivation in ES cells cultured in 2i
medium caused down-regulation of pluripotency markers
and up-regulation of early neural markers, including
Zfp521, which is essential and sufficient for driving the in-
trinsic neural differentiation of mESC [32] (Fig. 6e–j).
Down-regulation of pluripotency markers occurred also in
ES cells cultured in the presence of LIF, either in 2i
medium or in serum-containing ES cell medium (not
shown). Similar results were obtained using a conditional
Dicer flox/- cell line [33] upon Dicer excision with a CRE-
carrying lentiviral vector (Fig. 7a, b). These data indicate
that acute global miRNA down-regulation results in pluri-
potency destabilization.
Ground-state miRNAs affect the levels of chromatin
regulators
To get a better insight into the mechanisms of RISC
targeting, we performed small RNA-seq of cells during the
ES–ELA transition. This experiment had the additional
advantage of validating the robustness of Ago-RIP as a
method to measure RISC-mediated inhibition of mRNAs.
Indeed, we observed that miRNAs predicted to target
the most enriched or depleted RNAs in the Ago-RIP
were accordingly up- or down-regulated during the
ES–ELA transition (Fig. 7c, d). This result suggests that
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our method of analysis of mRNA/Ago enrichment is in-
deed predictive of miRNA–mRNA interactions.
More interestingly, the analysis of global miRNA ex-
pression at the ES–ELA cell transition highlighted a
number of up- and down-regulated miRNAs (Additional
file 1: Figure S4d; Additional file 5: Table S5), consistent
with the differential pattern of expression observed in
naïve and primed pluripotent cells [34, 35]. Specifically,
the level of expression of these miRNAs is higher in
naïve pluripotent cells and lower in ELA generated from
ES cells (Fig. 7e), making them part of a signature of
ground-state pluripotency. We found that the 3′ un-
translated regions (UTRs) of genes coding for DNMT,
KDM, and SWI/SNF are significantly enriched in pre-
dicted binding sites for the miRNAs down-regulated at
the ES–ELA cell transition compared with control 3′
UTRs (Fig. 7f ). High-affinity interactions predicted be-
tween 43 miRNAs most changing at the ES–ELA cell
transition and distinct members of DNMT, KDM, and
SWI/SNF are reported in Additional file 5: Table S5.
Fig. 5 a Flow cytofluorimetry analysis of TNG-A Nanog::GFP cells at 4 DIV. b GFP-positive cell ratios at 2 DIV and 4 DIV after inhibition of SmarcA4
(shSA4), DNMT (AZA), or KDM (CHQ) compared with control (Ctrl). c, d Similar analysis as in a and b, with a mESC line carrying GFP under the
human Nanog promoter (HNP). e, f RT-PCR gene expression analysis. Values are relative to β-actin mRNA expression. The lowest and highest
expression levels were normalized to 1 in the left and right histograms, respectively. g Nanog proximal promoter methylation. The scheme shows
the region of the mouse Nanog promoter amplified for bisulfite-treated DNA sequencing (bis-seq). Black circles in grid rows indicate CpG methylation
sites. The histogram shows the percentage of CpG methylation in different culture conditions as above. *p = 0.05, **p = 0.01, ***p = 0.001
(b, d, g, Student’s t-test; e, f, REST randomization test). Error bars show standard error
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Altogether, our observations suggest a direct role of
miRNAs in inhibiting the translation of DNMT, KDM,
and SWI/SNF in ES cells.
Since the high number of predicted miRNA–mRNA
interactions impeded their comprehensive experimental
validation, we focused on the effects of the miRNAs
showing the strongest predicted interaction with Kdm2b
(mmu-miR-150-5p and mmu-miR-27b-5p), SmarcA4
(mmu-miR-181c-5p and mmu-miR-425-5p), and Dnmt3b
(mmu-miR-295-5p) (Additional file 5: Table S5). To evalu-
ate miRNA–mRNA interactions, we co-transfected ma-
ture miRNAs together with reporters carrying enhanced
GFP (EGFP) followed by the 3′ UTR of Kdm2b, SmarcA4
or Dnmt3b in ES cells. We then indirectly evaluated the
amount of EGFP produced after 48 h in ELA cells or in
ES cells maintained in ES cell medium, measuring the
ratio between EGFP fluorescence and the fluorescence
produced by a DsRed-carrying plasmid (Fig. 7g–i; see
“Methods”). EGFP of 3′ UTR-carrying vectors was always
expressed at lower levels than EGFP of empty vector. In
the presence of Kdm2b, SmarcA4, or Dnmt3b 3′ UTRs,
however, EGFP levels were significantly lower in ES cells
than in ELA cells, indicating that a translational switch
driven by these 3′ UTRs occurs at the ES–ELA transition.
Moreover, all the miRNAs expected to bind to the 3′
UTRs with the best efficiency were able to inhibit EGFP
expression from a 3′ UTR-carrying vector in ELA cells.
According to the prediction of multiple miRNAs interact-
ing with one 3′ UTR, the co-transfection of one single
miRNA was not able to inhibit EGFP expression to the
levels observed in ES cells. Finally, EGFP expression was
less inhibited by miRNA co-transfection in cells main-
tained in ES medium (ES cells) than in cells differentiated
in chemically defined minimal medium (CDMM; ELA
Fig. 6 a CRISPR/Cas9 guide design: the single guide RNA (sgRNA; red square) was chosen to target a genomic region which is conserved
between Ago1 and Ago2 but avoiding off-targets. b Western blot of Ago* proteins in control (Ctrl) or Ago1–2 CRISPR ES cells 4 days after
transduction. c Western blot of Dnmt3b, SmarcA4, Kdm2b, Nanog, and GAPDH protein levels in ES cells cultured in 2i medium 4 days
after transduction with Ago1–2 CRISPR lentiviral vector compared with control cells transduced with non-targeting CRISPR vector (Ctrl CRISPR).
d mRNA levels of Dnmt3b, SmarcA4, and Kdm2b of cells as in c. e, f mRNA levels of pluripotency (e) or early neural commitment (f) in cells as
in c and d 8 days after transduction. g, h GFP immunodetection in a 46C Sox1::GFP mESC line cultured in 2i medium 8 days after transduction
with Ctrl CRISPR (g) or Ago1–2 CRISPR lentiviral vector (h). Scale bars, 50 microns. i, j Cell count (i) and cytofluorimetric analysis (j) of GFP-positive cells
as in g and h. *p = 0.05, **p = 0.01, ***p = 0.001 (e–f, REST randomization test; i, Student’s t-test). Error bars show standard error





Fig. 7 a, b RT-PCR analysis of mRNA levels of pluripotency (a) or early neural commitment (b) markers in Dicer flox/- conditional ES cells [33]
8 days after transduction with a CRE-GFP carrying lentiviral vector. Values are relative to β-actin mRNA expression. Expression levels were
normalized to GFP-transduced cells. c Log2 fold change (FC; y-axis) and mean value of miRNA expression (x-axis) between ES and ELA
cells. The blue dashed box indicates miRNAs significantly down-regulated (set “D”; mean log2 RPM ≥ 5 and log2 fold change ≤ −1) during
priming. d Z-scores of the expression of miRNAs predicted to bind top Ago-released (ΔE < −2; left panel) or top Ago-loaded (ΔE > 2; right panel) mRNAs
during the ES–ELA transition. Global miRNA/mRNA binding prediction was performed by the miRVestigator framework, which is designed to
take as input a list of co-expressed genes and return the miRNA most likely regulating these genes [82]. miRNA expression was evaluated
by small RNA-seq of ES cells cultured in 2i medium and LIF (ES#), ES cells cultured in LIF/serum (ES), ELA cells obtained from ES in 2iL (ELA#), and ELA
obtained from ES. Ago enrichment variation provides a good estimation of miRNAs changing at the ES–ELA transition. e Z-scores of expression (RPM)
of miRNAs selected in the blue box in c (set “D”), in ES cells cultured in 2i medium and LIF (ES#), ES cells cultured in LIF/serum (ES), ELA cells obtained
from ES in 2iL (ELA#), and ELA obtained from ES (ELA). f The distribution of predicted binding affinity, calculated as cumulative Miranda scores of set
“D” miRNAs in the 3′ untranslated region (UTR) of genes from the indicated families. The dashed red line marks the median score of a random gene set.
g–i Normalized enhanced GFP (EGFP)/DsRed fluorescence ratios as obtained by co-transfection of plasmids and miRNA mimics/controls in ES and ELA
cells (see “Methods”). All values, normalized on a DsRed plasmid as an internal control for transfection efficiency, are relative to the ratio
displayed by ES cells transfected with an EGFP plasmid devoid of any 3′ UTR. AU arbitrary units.*p = 0.05, **p = 0.01, ***p = 0.001; a, b, REST
randomization test; d–f, Wilcoxon test between pairs of conditions (d, e) or between each family and a randomized set of 3′ UTRs (f; see “Methods”);
g–i, Student’s t-test
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cells), in agreement with the evidence that higher amounts
of these miRNAs are already present in ES cells and,
therefore, their transfection is expected to show a smaller
additional effect. These results support the specificity of
some of the mRNA–miRNA interactions at the ES–ELA
cell transition predicted by in silico tools.
Discussion
Taking advantage of the spontaneous differentiation
program that ES cells undergo when deprived of
pluripotency-maintaining signals, we isolated and stud-
ied cells primed to differentiation (ELA) just after their
escape from the ground-state pluripotency state.
We performed Ago-RIP as a way to estimate RISC-
mediated inhibition of gene expression. Two new nu-
clear roles for Ago2 have been recently found in addition
to its main function as a component of RISC: one in
pre-mRNA splicing and one in transcriptional repression
[36]. We tend to exclude an influence of nuclear RNA in
our analysis as Ago–RNA immunoprecipitation was
performed on cytosolic protein fractions and strong
depletion of nuclear RNA species in Ago–RNA was
confirmed by the analysis of gene expression arrays (not
shown). Moreover, in light of the strong anti-correlation
observed when comparing Ago enrichment with ribo-
some enrichment (Fig. 4a) and the high consistency
between Ago-enriched mRNAs and their predicted tar-
geting miRNAs at the ES–ELA cell transition, we think
that the ratio of RNA splice junctions possibly immuno-
precipitated by Ago was negligible.
The strong correlation between the decrease of
Ago–RNA and the increase of ribosome occupancy
and MS detection at the ES–ELA transition strongly
supports a protein translation control. However, the
protein changes as measured by MS were bigger than
ribosome occupancy. We should consider that the
normalization method applied for polysome profiling
did not take into account the general up-regulation of
the translational machinery occurring during cell
priming but only measured the modulation of
ribosome occupancy above (or below) the overall
change (see “Methods”). This, together with the fold
change in ribosome occupancy exceeding the level
of total RNA up-regulation, would account for the
discrepancy.
We observed that the strongest variation, in terms
of the number of mRNAs changing their association
with Ago, happened at the ES–ELA transition, sug-
gesting an important role for this mechanism of protein
translation control in the maintenance of ground-state
pluripotency.
A number of mRNAs released by Ago are related to
DNA repair and replication. As ES cells and ELA corres-
pond to inner cell mass (ICM) and post-implantation
cells, respectively, the requirement of increased prolifer-
ation during priming is consistent with the higher cell
division rate occurring after embryo implantation [21].
Chromatin regulators, whose role in pluripotency has
been extensively discussed [2], are the other main class
of mRNAs released by Ago at the ES–ELA transition.
We found that DNMT, KDM, and SWI/SNF mRNAs are
already present in ground-state pluripotent cells but
their translation is either inhibited or kept at lower
levels.
During early embryonic development, DNMT activity
contributes to establish different genomic methylation
patterns, which characterize somatic differentiated cells
[37]. The observations that a number of pluripotency-
related genes are hypomethylated in stem cells [38] and
that global DNA hypermethylation occurs in epiblast
cells [39] suggest that the extensive reprogramming of
genomic methylation pattern is a key event in ES cell
priming. Global DNA hypomethylation is associated
with ground-state pluripotency [40–43] but, surprisingly,
appreciable levels of DNMTs are transcribed in naïve ES
cells [44]. Our finding that Dnmt1/3 mRNAs are signifi-
cantly released by RISC and that Dnmt1/3 protein trans-
lation is enhanced at the ES–ELA transition might
contribute to explain the presence of DNMT mRNAs in
ESCs.
Members of the KDM and SWI/SNF families that
we found to be released from Ago at the ES–ELA
transition can also act as transcriptional repressors.
Kdm2b (Jhdm1b) is responsible for the demethylation
of H3K36 [45], which marks the transcribed region of
active genes [46], while SmarcA4 is part of a complex
that is necessary to silence Nanog upon differenti-
ation [31]. Indeed, inhibiting the increase of SmarcA4
impedes the ES–ELA transition when LIF and serum
are removed from the culture medium. While this fact
is not in contrast with the requirement of SmarcA4 for
the maintenance of pluripotency [47], it confirms and ac-
counts for the evidence that SmarcA4 activity is necessary
for ES neuralization [4]. Overall, despite the fact that these
chromatin regulators are important for the maintenance
of pluripotency, we found that their up-regulation is cru-
cial for the control of priming.
Although we do not exclude that transcriptional regu-
lation of DNMT, KDM, and SWI/SNF might contribute
to cell priming, our results suggest that the release of se-
lected chromatin regulators from RISC inhibition during
priming may play a central role in reducing the perva-
sive transcription observed in ES cells [4] by reshaping
the nuclear landscape of the cell [22]. Moreover, the re-
lease from RISC inhibition of DNMT, KDM, and SWI/
SNF members could explain the intrinsic tendency of ES
cells to begin differentiating in the absence of external
signals [48].
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Naïve and primed mESC have distinct miRNA signa-
tures, with only a few genomic clusters accounting for
the majority of the difference in miRNA expression pro-
files [34, 35]. Global miRNA expression analysis of our
in vitro model revealed a consistent modulation during
the transition from ES to ELA cells. In agreement with
the literature [34, 35], members of the miR-302/367
cluster, which are more expressed in EpiSC, and the
miR-290/295 cluster, which are more abundant in ES
cells, were up- and down-regulated, respectively, at the
ES–ELA transition. The role of miRNAs in ES cell cycle
regulation, self-renewal, and their ability to differentiate
has been extensively assayed using cell lines in which
key components of miRNA processing, Dicer or Dgcr8,
were inactivated [49–51]. Moreover, recent studies of
global gene expression profiling performed at the single-
cell level highlighted that Dgcr8-deficient ES cells are
more similar to ES cells cultured in 2i and LIF rather
than in serum and LIF [52] and thus suggested that
miRNAs act as key mediators of the transition from
ground state pluripotency to primed states, with their
absence mimicking the inhibition of the Erk and GSK3
signaling pathways observed in 2i culture. This observa-
tion, together with many in vitro studies on the impact
of miRNAs in pluripotency, suggest that miRNAs are
dispensable for maintaining a ground state of pluripo-
tency in vitro [52]. However, Dicer inactivation dramat-
ically down-regulated Oct4 in the epiblast, causing the
loss of stem cells, possibly due to their premature differ-
entiation [7]. In our work, we tried to solve this apparent
contradiction between the in vitro and in vivo results by
using transient Dicer inactivation assays in vitro. To the
best of our knowledge, a key issue of all the in vitro
studies of Dicer and Dgcr8 inactivation published so far
is that they were performed in cell lines obtained
through extensive cell culture selection and stabilization.
For this reason, their use neither permitted the role
of gene expression buffering exerted by miRNAs in
naïve pluripotent cells to be studied nor allowed ana-
lysis of the changes that are “naturally” occurring dur-
ing cell priming. Indeed, by acutely inactivating Dicer
or RISC, we found that global miRNA activity is re-
quired to maintain pluripotency and that its perturb-
ation triggers the beginning of a differentiation
program in ES cell cultures which corresponds to
what is observed in vivo.
Our observations do not allow us to evince the exact
set of miRNAs that are necessary to maintain pluripo-
tency through the protein translation control of chroma-
tin regulators. By in silico analysis, we identified quite a
large number of miRNAs whose modulation at the ES–
ELA transition and predicted binding to DNMT, KDM,
and SWI/SNF mRNAs might support a direct role in cell
priming. For five of these, we showed the ability to
inhibit protein translation through the predicted 3′ UTR
target. Nevertheless, the high number of DNMT, KDM,
and SWI/SNF members possibly involved in the control
of cell priming and the consequent abundance of
miRNAs predicted to be interactors suggest that a large
set of miRNAs might be involved in orchestrating the in-
hibitory control of priming. The precise characterization
of each single miRNA–mRNA interaction is beyond the
scope of this work.
Conclusions
ES cell self-renewal is controlled by a small gene regula-
tory circuitry comprising a dozen interacting key
transcription factors whose activity seems sufficient to
maintain ground state pluripotency [53]. Nevertheless,
players other than transcription factors are likely to con-
trol the choice between self-renewal and differentiation
of ES cells. For instance, a global increase of protein
translation enforced by a hierarchy of translational
regulators is a feature of the switch between stem cell
self-renewal and differentiation [54]. This observation,
together with the evidence of pervasive transcription oc-
curring in ES cells [4], supports the hypothesis that a
tight control of protein translation, in addition to tran-
scriptional regulation, might account for ground state
pluripotency. This is consistent also with the observation
that RNA interference impairment in vivo causes the
loss of stem cells [7]. Our findings suggest that the
phenotype obtained in vivo after Dicer inactivation could
be caused by disregulated translation of key chromatin
regulators and place RISC-mediated control of protein
translation among the general mechanisms accounting
for the control of cell pluripotency. If this suggests a
primary mechanism of miRNAs in preserving ES cell
pluripotency and inhibiting the onset of embryonic
differentiation programs, on the other hand miRNA-
mediated control of chromatin regulators might main-
tain cells in a metastable state, which could rapidly be
converted into priming to cell differentiation upon the
removal of stemness-sustaining factors. Accordingly,
priming could be seen as a process in which two epigen-
etic mechanisms are layered one on the other (Fig. 8): a
first layer, which is microRNA-mediated, on which lies a
second layer consisting of chromatin-based modulation
of transcription.
Methods
ES culture and neuralization
Murine ES cell lines E14Tg2A, 46C, and TNG-A
(transgenic Sox1-GFP and Nanog-GFP ES cells, kindly
gifted by Dr. A. Smith, University of Cambridge, UK) [16,
48] and the Dicer flox/null ES cell line (generously pro-
vided by Dr. G. Hannon, Cancer Research UK Cambridge
Institute) [33] were cultured on gelatin-coated tissue
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culture dishes at a density of 40,000 cells/cm2. ES cell
medium, which was changed daily, contained GMEM
(Sigma), 10 % fetal calf serum, 2 mM glutamine, 1 mM
sodium pyruvate, 1 mM non-essential amino acids,
0.05 mM β-mercaptoethanol, 100 U/mL penicillin/
streptomycin, and 1000 U/mL recombinant mouse LIF
(Invitrogen). For ground-state reprogramming of ES cells,
medium was switched for three to five passages to 2iL
medium: GMEM (Sigma) supplemented with N2/B27 (no
vitamin A; Invitrogen), 2 mM glutamine, 1 mM sodium
pyruvate, 1 mM non-essential amino acids, 0.05 mM
β-mercaptoethanol, 100 U/mL penicillin/streptomycin,
1 μM MEK inhibitor PD0325901, 3 μM GSK3 inhibitor
CHIR99021, and 1000 U/mL recombinant mouse LIF [55].
Chemically defined minimal medium (CDMM) for
neural induction consisted of DMEM/F12 (Invitrogen),
2 mM glutamine, 1 mM sodium pyruvate, 0.1 mM non-
essential amino acids, 0.05 mM β-mercaptoethanol, and
100 U/mL penicillin/streptomycin supplemented with
N2/B27 (no vitamin A; Invitrogen). The protocol of ES
neuralization consisted of three steps (Fig. 1a). During
step 1, dissociated ES cells were washed with DMEM/
F12, aggregated in agar-coated culture dishes (65,000
cells per cm2), and cultured as floating aggregates in
CDMM for 2 days. The second day, 75 % of the CDMM
was renewed.
In step 2, ES cell aggregates were dissociated and
cultured in adhesion (65,000 cells per cm2) on poly-
ornithine (Sigma; 20 μg/ml in sterile water, 24 h coat-
ing at 37 °C) and natural mouse laminin (Invitrogen;
2.5 μg/ml in PBS, 24-h coating at 37 °C) for 4 days,
changing CDMM daily. In step 3, after a second dis-
sociation, ES cells were cultured for an additional
4 days in CDMM devoid of B27 supplement to drive
terminal differentiation, using the same type of seed-
ing density and coated surface described for step 2.
Serum employed for trypsin inactivation was carefully
removed by washing with DMEM/F12. LIF serum
withdrawal coupled to culturing as cell aggregates for
the first 2 days results in a very low amount of cell
death [9]. Cell viability, which was monitored by a trypan
blue exclusion test and cell counting, was more than 90 %
and did not vary significantly between different steps of
the differentiation protocol. Analysis of global gene
Fig. 8 Two-layer model of epigenetic control of pluripotency. A marked release from RISC characterizes the ES–ELA transition (priming), whereas
transcriptional regulation occurs preferentially at the ELA–NPC transition (neuralization). Our data suggest a causal link between the two
phenomena as the pool of de-repressed genes contains distinct chromatin regulators which could overcome the epigenetic barrier between the
primed state and ground-state pluripotency. Thus, ground-state miRNAs, which are down-regulated during priming, could shield naïve pluripotent
cells from the epigenetic transition required for the onset of embryonic differentiation programs
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expression on GO terms of apoptosis between ES and
ELA cells showed no significant change (GO 0006917, in-
duction of apoptosis, p = 0.668; GO 1900117, regulation of
execution phase of apoptosis, p = 0.373; GO 0097194, exe-
cution phase of apoptosis, p = 0.559). The following fac-
tors were tested by addition during step 1: 5-azacytidine
(Sigma-Aldrich; 50 nM) and 5-carboxy-8-hydroxyquino-
line (Sigma-Aldrich; 100 μM).
Ago-bound RNA immunoprecipitation
In order to isolate cellular mRNAs that are bound by
Ago proteins, we used a RIP-Assay Kit for microRNA
(MBL Japan) according to the manufacturer’s instruc-
tions. The protocol includes a step for the isolation of
the cytosolic fraction, which allowed us to avoid the co-
precipitation of nuclear Ago and RNAs. Anti-pan Ago
antibody, clone 2A8 (Ago*; Millipore MABE56) [56],
mouse total IgG (Millipore; 12-371), or Anti-Ago2 anti-
body, clone 9E8.2 (Millipore; 04-642) were used for im-
munoprecipitation (IP). For each single experiment, we
started from 107 cells collected by pooling three (ES) to
ten (ELA, NPC, NPC/NEU Neu) different samples. The
binding of RNP to the beads was confirmed after IP by
western blotting with anti-Ago* antibody (Additional
file 1: Figure S1a). The global screening of Ago–RNA
by microarray analysis was performed following IP
with Anti-pan Ago antibody (see the next section). Three
independent experiments were performed. IP with Anti-
Ago2 antibody was used to validate association of selected
mRNAs with Ago by RT-PCR using a spike-in as a refer-
ence (Additional file 1: Figure S2f, g). Tol2 transposase
mRNA (8 ng) synthesized in vitro was added to each pellet
as a spike-in before IP. Mouse total IgGs were always used
as an IP negative control. Two independent experiments
were performed.
Microarray hybridization and data analysis
Total RNA was extracted with NucleoSpin RNA II col-
umns (Macherey-Nagel). RNA quality was assessed with
an Agilent Bioanalyzer RNA 6000 Nano kit; 200 ng of
RNA was labeled with Low Input Quick Amp Labeling
Kit, One-Color (Agilent Technologies, purified and hy-
bridized overnight onto an Agilent SurePrint G3 Mouse
Gene Expression Array (8x60K) before detection accord-
ing to the manufacturer’s instructions. An Agilent DNA
microarray scanner (model G2505C) was used for slide
acquisition and spot analysis was performed with
Feature Extraction software (Agilent Technologies).
Data were background-corrected and quantile normal-
ized among arrays using the Bioconductor package limma
[57]. In order to sort out Ago-released or Ago-loaded
mRNAs in Fig. 1c, we employed the following analysis
pipeline (schematized in Additional file 1: Figure S1b):
1. For a gene probe to be considered significantly
bound to Ago, we assumed that the distribution of
signal is bimodal, with a fraction of genes not bound
(first peak, background) and another displaying a
heterogeneous degree of binding. In fact this is what
we observed in the distribution of fluorescence
intensity (Additional file 1: Figure S1c). After fitting
the distribution to a Gaussian mixture model [58],
we set a threshold T1 equal to (μ1 + 3σ1), which
corresponds to p = 0.001 of false positive bound
mRNA. Only mRNAs above this threshold were
taken into account.
2. For each step, Ago enrichment (En) was evaluated as
log2 ratio between Ago–RNA and total RNA levels
after quantile normalization and an arbitrary
threshold of T2 ≥ 2 was applied in order to capture
only the most enriched genes. Conversely, genes
with enrichment less than 0.5 were considered not
significantly enriched (T3; this value was relaxed to
1.2 for subsequent analyses; e.g., GO analysis and
Fig. 4b–d).
3. For each transition, genes released from Ago have
En ≥ T2 and En+1 ≤ T3 (as depicted in Additional file
1: Figure S1b, right panel) while, conversely, genes
loaded by Ago have En ≤ T3 and En+1 ≥ T2.
4. Finally, a threshold on the differential enrichment
between steps (ΔE = En+1 − En) was used as a filter to
sort out top regulated genes (|ΔE| ≥ 1.5).
Gene ontologies over-represented in the subset of Ago-
released genes during the ES–ELA transition were
evaluated using the web service Database for Annotation,
Visualization and Integrated Discovery (DAVID) [59].
Genes that were differentially expressed between ES
and ELA cells with |log2FC| ≥1 (where FC is fold
change), corrected p value <0.05, and mean log2 expres-
sion ≥7.5 (n = 1207; Additional file 6: Table S4) were
used for hierarchical clustering in order to assess the
effect of manipulations. RNA from three different sets of
treatments was pooled.
We changed the cutoffs for different analyses of global
mRNA expression because the dynamic ranges of
mRNA change were different in the different experimen-
tal settings: we used log2 > 2.5 when comparing ES, ELA,
NPC, and neuron cells, which are very different from
each other, while we used log2 > 1 when comparing ES
cells with ELA cells, which are more similar.
Euclidean distance and a complete linkage algorithm
were employed for clustering.
To assay the concordance of gene modulation between
different conditions and obtain the statistical signifi-
cance, we used a sign test. The sign test was performed
comparing the fold change of ES–ELA cells to the fold
change of treated/control ELA cells for each gene.
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Randomized sets of data used as control were obtained
by substituting the fold changes of treated/control data-
sets with fold changes of random genes (randomization
1) or by scrambling the order of treated/control ELA cell
values (randomization 2).
Profiling of ribosome-associated RNA (polysome profiling)
For the pull-down of ribosome-associated RNA we were
inspired by the TRAP (translating ribosome affinity
purification) protocol developed in the laboratory of
Dr. Nathaniel Heintz [26, 27]. In short, this protocol
is based on the pull-down of ribosomes using the large
subunit protein Rpl10a, which is fused with GFP. We
modified this protocol in order to pull down the endogen-
ous Rpl10a protein as this would allow us to sample trans-
lation without altering the endogenous translational
machinery. Immediately before the analysis, ES and ELA
cells were trypsinized and resuspended in the appropriate
growth medium supplemented with 100 μg/mL cyclohexi-
mide in order to stall ribosomes. After a 15 min incuba-
tion at 37 °C, cells were recovered and washed with ice-
cold PBS plus 100 μg/mL cycloheximide to remove traces
of serum and medium. Each sample (for both ELA and ES
cells) included approximately 20 million cells and we con-
ducted all experiments in duplicate. The samples were re-
suspended in 1 mL ice-cold lysis buffer (20 mM HEPES/
KOH pH 7.3, 150 mM KCl, 10 mM MgCl2, 1 % IGEPAL
CA 630 (Sigma), 0.5 mM DTT, 100 μg/mL cycloheximide,
1 pill/10 mL complete MINI EDTA free protease in-
hibitor (Roche), 3 μL/mL RNAsin RNAse inhibitor
(Promega), 3 μL/mL SUPERASEin RNAse inhibitor
(Life Techologies)) and incubated on ice for 10 min
before being triturated in a chilled dounce homogenizer
with approximately 20 strokes. After lysis was completed,
cellular debris (mostly formed by nuclei and fragments of
cell membrane) was removed by centrifugation at 2000
RCF for 10 min. After centrifugation, 0.1 volumes of
300 mM 1,2-diheptanoyl-sn-glycero-3-phosphocholine
(DHPC, Generon Ltd) were added to each sample to fur-
ther solubilize ribosomes, followed by a 10 min incubation
on ice and by a second centrifugation at 20,000 RCF for
10 min. The final clarified lysate was transferred to a new
low-retention tube and 0.1 volumes were removed to be
used as “input” samples for the measurements of total
RNA levels. To immunoprecipitate ribosomes, 16 μg
of anti-Rpl10a antibody (Sigma, catalogue number
WH0004736M1) or an equivalent amount of anti-GFP
antibody (control, Sigma catalogue number G1544) were
added to each sample and incubated overnight with end-
to-end agitation at 4 °C. The following day, 200 μL of
30 mg/mL Protein-G Dynabeads (Life Technologies) were
washed in PBS plus 0.1 % Tween 20 (PBST), blocked in
PBST plus 1 % bovine serum albumin (BSA) for 1 h, and
added to the lysate/antibody mix. Beads were incubated
overnight at 4 °C with end-to-end agitation. The following
day the precipitated ribosomes were washed four times in
1 mL high-salt buffer (20 mM HEPES/KOH pH 7.3,
350 mM KCl, 10 mM MgCl2, 1 % IGEPAL CA 630
(Sigma), 0.5 mM DTT, 100 μg/mL cycloheximide) and
RNA was extracted using the RNEasy Micro kit (Qiagen)
as per the supplier’s protocol. The results were quantified
by spectrophotometry (Nanodrop) and capillary electro-
phoresis (Bioanalyzer RNA Nano kit; Additional file 1:
Figure S2b). RNA (2 μg) was used to prepare each RNA-
seq library. Purified RNA was ribosome-depleted using
the RIBO-Zero Gold kit (Illumina), which uses magnetic
beads conjugated to rRNA-specific oligonucleotides to re-
move ribosomal RNA. The final purified RNA was ana-
lyzed by capillary electrophoresis (Bioanalyzer Pico Kit)
and retro-transcribed and cloned into a sequencing library
using the SCRIPTSeq v2 library preparation kit (Illumina)
according to the supplier’s protocol. Sequencing libraries
were evaluated by Bioanalyzer (to verify the size distribu-
tion of fragments) and quantified by quantitative PCR
using primers specific for Illumina adaptors (KAPA library
quantification kit). All eight libraries (two replicates for
ELA and ES cells, both IP and input) were mixed at a
similar final concentration before cluster generation and
sequencing on a HiSeq 2500 instrument.
Polysome profiling data analysis
All the libraries were sequenced in a multiplexed lane
using v4 chemistry on a Illumina HiSeq instrument, pro-
ducing approximately 250 million reads of raw data.
After demultiplexing, each library comprised between 20
and 50 million reads, with the input library overall pro-
ducing fewer reads than the ribosome IP libraries. This
effect was most likely due to an unequal loading and to
the different nature of the input RNA samples (including
a variety of RNA and small RNA types, while the ribo-
some IP libraries were mostly composed of messenger
RNAs) and raised no concern for the subsequent ana-
lysis (Additional file 1: Figure S2a).
All the datasets were subject to quality control using
the fastx toolkit software through the following analyses:
(1) quality score per cycle, (2) nucleotide distribution
per cycle, (3) PCR duplicates (estimated by collapsing
the reads). All libraries yielded good quality data, with
the exception of one of the replicates for the ELA input
sample, which showed a lower complexity and higher
amount of duplication (resulting in lower mapping to
the transcriptome during the later steps of the analysis;
data not shown).
Reads contained in each of the remaining libraries
were mapped to the mouse transcriptome (USCS mm10
release) using the software TopHat2 [60], which ac-
counts for spliced transcripts. Repeated regions (i.e.,
transposable elements) were excluded and a maximum
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of two hits on the genome and two mismatches were
allowed during mapping. Mapped reads were assigned to
genes using the htseq-count script [61], which counts
features overlapping each gene in the released transcrip-
tome. Counts were calculated for each gene_id, collaps-
ing eventual splicing isoforms. The resulting raw counts
were normalized using the DESeq2 R package [62]. The
DESeq scaling factor for a given lane is computed as the
median of the ratio, for each gene, of its read count over
its geometric mean across all samples. It is important to
notice that this normalization (and, effectively, any other
normalization applicable to our data) is based on the as-
sumption that the majority of genes are not differentially
expressed among samples. This is not necessarily true
during differentiation as there are reports indicating a
massive up-regulation of the translational machinery
[54], which would imply a higher read number for most
genes during the ES–ELA transition. Unfortunately, it is
impossible for any “internal” normalization method to
account for global changes. As a consequence, our
analysis of differential translation only indicates as sig-
nificant genes that vary above or below the overall
change level. We believe that this further increases the
significance of our findings since our results include
genes subject to a specific regulation rather than a global
effect.
After normalization, we analyzed our results to assess
correlation among datasets and among conditions
(through hierarchical clustering and principal compo-
nent analysis; Additional file 1: Figure S2c, d). The
results indicated that one of the replicates for the
ELA input sample showed poor correlation with both
the other input replicate and the other datasets
(ELA.input.1; Additional file 1: Figure S2c, d). This,
together with the lower mappability, lower read quality,
and increased amount of PCR duplicates (as described
above), led us to exclude this replicate from further pro-
cessing. While this reduces the statistical power of our
analysis, the fact that we are filtering our results to include
only genes presenting high expression and a high degree
of change in their ribosome enrichment makes us
confident that our conclusions are still significant.
The remaining libraries were filtered to include only
genes with an average of 50 counts in at least one of the
two conditions (ES or ELA). This threshold was chosen
to exclude less-expressed genes, which would be the
most affected by the inherent noise of our method. For
all the genes passing this first filter, ribosome enrich-
ment was calculated by dividing the average ribosome IP
count by the input count. A second filter was then ap-
plied, excluding genes for which the standard deviation
of the counts accounted for more than 20 % of the aver-
age value. This filtering produced a list of approximately
5000 genes, for which we calculated a log2 fold change
in ribosome enrichment (ELA average enrichment/ES
average enrichment; log2RiboΔE). For our GO enrichment
analysis, we considered only genes with log2RiboΔE >1
during differentiation, producing a final list of ~400 differ-
entially regulated genes.
While the GO category enrichment results we ob-
tained were all highly significant according to multiple
statistics tests, we couldn’t properly assess the signifi-
cance of changes in the ribosome enrichment of individ-
ual genes due to our decision to remove the faulty
replicate in the ELA input dataset. We nevertheless fil-
tered our data to exclude genes with high replicate-to-
replicate variation and low expression and reported
those with the highest changes, in both directions, in
our raw data (Additional file 2: Table S1). Some of the
genes individuated by our other analyses (Ago IP and
protein MS) fell short of matching our filter in the ribo-
some enrichment data; nevertheless, they showed a clear
increase in enrichment, which was consistent with the
modulation highlighted by the other techniques. We de-
cided to show these results since we believe that the fact
that we obtained similar results through multiple and
complementary analysis types constitute a strong proof
of significance.
Semiquantitative real-time PCR
Total RNA was extracted from ES cells or tissue samples
with NucleoSpin RNA II columns (Macherey-Nagel). ES
cells from at least two to three different wells of 24-well
plates were always pooled together to compensate for
variability in cell seeding. RNA quantity and RNA
quality were assessed by gel electrophoresis. For each
sample, 200 ng of total RNA was reverse-transcribed
(Eurogentech, RT Core kit). Amplified cDNA was quan-
tified using GoTaq qPCR Master Mix (Promega) on a
Rotor-Gene 6000 (Corbett). Primers used for amplifica-
tion which were not previously reported [9] were taken
from PrimerBank [63]. Amplification take-off values
were extracted using the built-in Rotor-Gene 6000 rela-
tive quantitation analysis function and relative expres-
sion was calculated with the 2-ΔΔCt method, normalizing
to the housekeeping gene β-actin. Standard errors shown
as error bars in all histograms were obtained from the
error propagation formula as described in [64]; the
statistical significance of three independent experiments
was probed with a randomization test using the REST
software [65].
Immunocytodetection
Cells prepared for immunocytodetection experiments
were cultured on poly-ornithine/laminin-coated round
glass coverslips. Cells were fixed using 2 % paraformal-
dehyde for 10–15 min, washed twice with PBS,
permeabilized using 0.1 % Triton X100 in PBS, and
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blocked using 0.5 % BSA in PBS. Primary antibodies
used for microscopy included Oct3/4 (1:200; Santa Cruz
Biotechnology C-10; sc-5279), Nanog (1:300; Novus
Biologicals; NB100-58842), acetylated N-tubulin (clone 6-
11B-1; 1:500; Sigma; T7451), neuronal class III β-tubulin
(1:500; Covance; MRB-435P), Nestin (1:200; Millipore;
MAB353), Pax6 (1:400; Covance; PRB-278P), and GFP
(1:1000; Life Technologies; A-6455). Primary antibodies
were incubated for 2 h at room temperature; cells were
then washed three times with PBS (10 min each). Alexa
Fluor 488 and Alexa Fluor 568 anti-mouse or anti-rabbit
IgG conjugates (1:500; Molecular Probes; A-11001 and A-
11011, respectively) were incubated for 1 h at room
temperature in PBS containing 0.5 % BSA for primary
antibody detection, followed by three PBS washes (10 min
each). Nuclear staining was done with DAPI (2 μg/mL;
Sigma).
The same protocol was applied on sections of embry-
oid bodies after fixation (2 h at 4 °C in 2 % PFA), dehy-
dration (overnight at 4 °C in 30 % sucrose/PBS),
inclusion in Tissue-Tek OCT compound (Sakura), and
cryostat sectioning (12–16 μm) on SuperFrost glass
slides (Thermo).
Nuclear extract preparation and proteomics sample
pre-processing
About 107 cells per sample were dissociated, washed
with ice-cold PBS, and resuspended in 400 μL of nuclear
extraction buffer (50 mM Tris-Hcl pH 7.9, 10 mM KCl,
0.2 % NP40, 10 % glycerol, and 1 mM PMSF) for 3 min
in ice, then nuclei were pelleted by centrifugation at
6000 RPM for 3 min at 4 °C. Nuclei were washed twice
with 1 mL of nuclear extraction buffer devoid of NP40;
before proceeding to mass spectrometry analysis, a small
aliquot was lysed in loading buffer and used for western
blotting to confirm that the enrichment in nuclear frac-
tion was homogeneous between samples.
Nuclear extracts were lysed using lysis buffer contain-
ing TRIS HCl 50 mM pH 8.1, 0.5 % Triton X-100, and
0.25 % deoxycholic Na and sonicated. Samples were cen-
trifuged at 10,000 g for 10 min at 4 °C to discard cell
debris and buffer detergent was removed using a deter-
gent removal spin column (Pierce, Thermo Scientific,
USA). Protein concentration was determined by bicinch-
oninic acid assay (Pierce, Thermo Scientific, USA). We
diluted 100 μg of protein in 25 mM of ammonium
hydrogen carbonate (pH 8) and reduction was obtained
by adding 5 mM dithiothreitol with an incubation of
20 min at 80 °C. Iodoacetamide was added to the
samples to a final concentration of 10 mM and incu-
bated in the dark for 30 min at 37 °C. Digestion was
performed incubating overnight with 100:1 substrate:-
trypsin (Roche, Germany) at 37 °C. Nucleic acid con-
taminants were removed with Amicon Ultra-3 K
centrifugal devices (Merck Millipore, Germany), then
flow-through containing peptides was loaded on a C18
cartridge in order to eliminate debris and filtered with
0.22 μm filter.
Liquid chromatography-tandem MS analysis
Chromatographic separation of peptides was performed
using a nano-HPLC system (Eksigent, ABSciex, USA).
The loading pump pre-concentrated the sample in a
pre-column cartridge (C18 PepMap-100, 5 μm 100 A,
0.1 x 20 mm; Thermo Scientific, USA).
Chromatographic separation of peptides was performed
using a C18 PepMap-100 column (3 μm, 75 μm×
150 mm; Thermo Scientific, USA) at a flow rate of
300 nL/min. Runs were performed with eluent A
(Ultrapure water, 0.1 % formic acid) under a 60 min
linear gradient from 25 to 40 % of eluent B (acetonitrile
(Romil, UK), 0.1 % formic acid) followed by 10 min of a
purge step and a 20-min re-equilibration step. The col-
umn was directly coupled to a TripleTOF 5600 System
(ABSciex, USA), equipped with a DuoSpray ion source
(ABSciex, USA). Peptides eluted from chromatography
were directly processed using a TripleTOF 5600 mass
spectrometer (ABSciex, USA). The mass spectrometer
was controlled by Analyst TF 1.6.1 software (ABSciex,
USA). For information-dependent acquisition (IDA) ana-
lysis, survey scans were acquired in 250 ms and 25 prod-
uct ion scans were collected if exceeding a threshold of
125 counts per second (counts/s). Dynamic exclusion was
set for one-half of peak width (∼8 s), then the precursor
was refreshed off the exclusion list. MS/MS data were
processed with ProteinPilot Software (ABSciex, USA)
using the Paragon and Pro Group Algorithms and UniProt
2013 as protein database for Mus musculus. The false dis-
covery rate (FDR) analysis was done using the integrated
tool in the ProteinPilot software and a confidence level of
95 % was set. Label-free statistical comparative analysis
[66] was performed using MarkerView (ABSciex, USA).
The ion chromatograms of high confidence peptides
identified by ProteinPilot were extracted using PeakView
Software (ABSciex, USA), then MS peak areas and identi-
fications were imported into MarkerView. Normalization
of the total plaque area (plaque size) was done using a glo-
bal normalization of profiles (total protein content). Prin-
cipal component analysis (data not shown) was performed
in order to determine groupings among the data set. The
two groups (ES and ELA, n = 3) were compared with t-test
using a threshold p value ≤0.05 and fold change >2.
Western blotting
Cells were lysed with RIPA buffer (50 mM Tris-HCl
pH 7.6, 1 % NP40, 0.5 % deoxycholic acid, 150 mM
NaCl, 1 mM EDTA, 1 mM PMSF, 1 % SDS) supple-
mented with Complete Protease Inhibitor Cocktail
Pandolfini et al. Genome Biology  (2016) 17:94 Page 17 of 22
(Roche); lysate was incubated for 30 min on ice and
sonicated three times for 10 sec each on medium power
in order to reduce viscosity. Supernatant was harvested
by centrifugation (10 min at 13,000 RPM, 4 °C) and
quantified with a Micro BCA Protein Assay Kit (Thermo
Scientific). Samples were denatured by adding sample
buffer (LDS Sample Buffer, Thermo Scientific) and
boiled for 10 min on a thermal block at 99 °C. The total
protein extract (10 to 50 μg) was resolved on 8–10 %
acrylamide gels, transferred on a nitrocellulose mem-
brane (Hybond-c Extra, GE Healthcare), blocked with
5 % milk proteins in TBST (50 mM Tris pH 7.6,
150 mM NaCl, 0.05 % Tween-20), and probed with
primary antibodies, including Dnmt3b (1:2000; Imgenex/
Novus Biologicals; IMG-184A), SmarcA4 (1:1000;
Abcam; ab4081), Kdm2b (1:2000; Merck Millipore; 09-
864), PolII (clone CTD4H8; 1:1000; Millipore), α-tubulin
(clone B-5-1-2; 1:5000; Sigma-Aldrich; T6074), GAPDH
(Sigma-Aldrich; G9545), panAgo clone 2A8(1:250;
Millipore; MABE56) and Ago2 clone 9E8.2 (1:2000;
Millipore; 04-642). After 1 h of incubation, the membrane
was washed three times with TBST (15 min each) and
probed with a HRP-conjugated secondary anti-mouse or
anti-rabbit antibody for 1 h (Santa Cruz Biotechnology;
sc-2005 and sc-2030, respectively). After three more
washes, signal was revealed by means of an enhanced
chemiluminescence kit (G&E Healthcare) on a BioMax
XAR Film (Kodak).
Lentiviral vector construction and use
Knock-down vectors against SmarcA4 or luciferase
(shSA4 and shCtrl, respectively) were constructed in
order to sustain high expression of shRNAs in both ES
and differentiating conditions: an IRES-PuroR-shRNA
cassette from pGIPZ vectors (Open Biosystems) was ex-
cised by double restriction with NotI and MluI (NEB),
filled in with T4 DNA polymerase (NEB), and inserted
into a modified pWPXLd vector (Addgene number
12258; original GFP was swapped with DsRed with re-
striction sites MluI/XmaI) which was cut with NdeI and
blunted as above. This resulted into a self-inactivating
transfer plasmid carrying a DsRed-IRES-Puromycin re-
sistance cassette with the shRNA of interest, driven by
the strong ubiquitous promoter EF1α. As a reporter of
human Nanog promoter activity we employed a PL-SIN-
Nanog-EGFP vector [67] (Addgene, number 21321).
CRISPR/Cas9 vectors were based on LentiCRISPR v2
[68] (Addgene, number 52961) and constructed follow-
ing the manufacturer’s instructions. Briefly, vector was
linearized with BsmBI (NEB), dephosphorylated with calf
intestinal phosphatase (NEB), and ligated with an oligo
duplex obtained by annealing two single-stranded DNA
sequences synthesized in vitro and 5′-phosphorylated by
T4 Polynucleotide Kinase (NEB). The following oligos
were designed and synthesized for Ago1–2 and control
(CTRL) guides, respectively: Ago1–2_fw, CAC CGC
GCA TCA TCT TCT ACC GCG A; Ago1–2_rev, AAA
CTC GCG GTA GAA GAT GAT GCG C; CTRL_fw,
CAC CGG CGA GGT ATT CGG CTC CGC G;
CTRL_rev, AAA CCG CGG AGC CGA ATA CCT CGC
C. For CRE-GFP vector construction, a CRE-NLS-IRES
cassette from CRE-PuroR vector (Addgene, number
30205) was excised by double restriction with NotI and
NdeI (NEB), filled in with T4 DNA polymerase (NEB),
and inserted into a pWPXLd vector (Addgene, number
12258) which was cut with MluI and blunted as above.
This resulted in a self-inactivating transfer plasmid car-
rying a CRE-IRES-EGFP cassette driven by the strong
ubiquitous promoter EF1α.
Lentiviral vectors were produced by transient transfec-
tion of 293 T cells using 150 nM polyethylenimine (PEI)
reagent (Sigma) with either PL-SIN-Nanog-EGFP, shCtrl,
or shSA4 plasmids, together with the Δ8.91 packaging
and a VSV-G envelope expressing plasmids [69] in a ra-
tio of 20 μg:15 μg:5 μg, respectively, per single 100-mm
dish. Transfection medium was discarded 24 h after
transfection, then viral particles were collected at 48 h
and 72 h, pooled and frozen at −80 °C.
For shRNA-mediated knock-down experiments, ES
cells underwent two rounds of spinoculation (1 h, 1100
RCF at room temperature) [70], then transduced cells
were selected in puromycin (0.75 μg/mL) for 48 h before
ELA formation (Additional file 1: Figure S3a). By 0 DIV
more than 90 % of cells were DsRed+, achieving a
knock-down of SmarcA4 mRNA to 21.2 % of the expres-
sion level in shCtrl-infected cells (Additional file 1:
Figure S3b).
For CRISPR/Cas9 experiments, cells were transduced
and selected as above and maintained in ES medium
(either serum and LIF or 2i plus LIF), achieving gen-
omic editing (Additional file 1: Figure S4b) and strong
down-regulation of Ago* protein levels (Fig. 6b) by
4 days after transduction. Rapamycin (100 nM; Abcam) or
MG-115 (1 μM; Sigma-Aldrich) activity was tested by
adding the drugs to the culture medium 48 h after
transduction.
For Dicer conditional knock-out experiments, a
Dicer fl/- ES cell line was transduced with CRE-GFP
lentiviral vector, then, after 48 h, GFP-positive cells
were sorted by cytofluorimetry and reseeded for cul-
turing in ES medium. Control (not excised) cells
were transduced with pWPXLd vector devoid of CRE
recombinase.
FACS analysis
Cells were detached by trypsinization, washed, and re-
suspended in PBS at room temperature, then analyzed
with a FACSCalibur cytometer (BD Bioxciences). At
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least 25,000 events per sample were collected. Data were
processed with Bioconductor package flowCore [71].
HNP cell line generation
For the generation of a mouse ES cell line carrying
human Nanog proximal promoter (Additional file 1:
Figure S3d), E14Tg2A cells in FCS plus LIF were in-
fected with PL-SIN-Nanog-EGFP lentiviral vector. After
six passages from transduction, cells were detached
by trypsinization, washed, and resuspended in PBS,
2 % FBS, and 2 mM EDTA and kept on ice. The
Nanog::GFP+ population (Additional file 1: Figure S3e)
was sorted on a FACS Aria II Flow Cytometer (BD
Biosciences) and reseeded as a polyclonal line for
amplification (HNP) to average positional effects of
promoter insertion. The resulting cell line remains
GFP+ after multiple passages in 2iL (data not shown)
but promptly switches off fluorescence upon differen-
tiation (Additional file 1: Figure S3f ), with kinetics
consistent with developmental Nanog regulation. EGFP
mRNA levels correlate well with that of endogenous
Nanog, as seen by real-time PCR (Additional file 1:
Figure S3g).
Nanog promoter methylation assay
For the characterization of Nanog promoter methylation
status, we extracted genomic DNA with the Wizard SV
Genomic DNA Purification System (Promega). DNA
(500 ng) was bisulfite-treated using an EZ DNA
Methylation-Lightning Kit (Zymo Research) and the re-
gion of proximal Nanog promoter (Fig. 5g) was ampli-
fied by PCR with a primer set from [72] and cloned into
a pGEM-T Easy vector (Promega). For each experiment,
DNA obtained from 10 to 15 different colonies trans-
formed with plasmid was sequenced on an ABI3730
DNA analyzer (Applied Biosystems) and data were ana-
lyzed with BiQ Analyzer software [73].
Small RNA-seq and analysis
The sequencing procedure was done using Illumina
Sequencing By Synthesis technology. Total RNA
(1 μg) extracted with a miRNeasy Mini kit (Qiagen)
was used for library preparation (Illumina, TruSeq
Small RNA Sample Prep Kit) following the manufac-
turer’s description. Libraries were sequenced on a
miSeq (Illumina) running in 50-bp single-read mode
using sequencing chemistry v3 and demultiplexed in
FASTQ format using CASAVA v.1.8 (Illumina).
Library adaptors were trimmed with Trimmomatic
[74] and reads were mapped to the mouse genome
(NCBI37/mm9) with Bowtie [75]. miRNAs reads were
annotated according to miRbase20 [76] and summa-
rized using featureCounts [77]. Normalization was
performed as reads per million (RPM) and
differential expression was evaluated with the R pack-
age edgeR [78].
In silico analysis of 3′ UTR binding
We predicted the affinity of the specific miRNA subset
which is expressed in ES cells and is down-regulated
during the ES–ELA transition (log2 mean count per
million ≥5; log2 fold change ≤ −1; Additional file 5:
Table S5) towards different mRNA families (as in
Additional file 3: Table S2). For this purpose, we took
advantage of the UCSF Table Browser data retrieval
tool [79], which allows batch downloading of the 3′
UTR sequences of the genes of interest; when genes
had several 3′ UTR variants, the longest one was
taken into account. We employed the miRanda algo-
rithm, which searches for complementarity matches
between miRNAs and 3′ UTRs using dynamic pro-
gramming alignment and thermodynamic calculation
[80] (Additional file 5: Table S5). We set a minimum
score of 140 and a maximum energy of −10 kcal/mol
as thresholds. For each gene, miRNA scores were
summed and the distributions of sums in different
families were tested for statistically significant difference
with a Wilcoxon test. 3′ UTR randomization was obtained
by scrambling the 3′ UTR sequences [81]. Global
miRNA–mRNA binding prediction was performed using
the miRVestigator framework [82] submitting as inputs
the lists of either the top Ago-released (ΔE ≤ −2) or Ago-
loaded (ΔE ≥ 2) mRNAs during the ES–ELA transition.
Only miRNAs with a p value ≤0.002 were retained in the
z-score analysis.
3′ UTR transfection assay
The 3′ UTR of mouse Kdm2b, SmarcA4, and Dnmt3b
genes were PCR-amplified from E14 ES cell genomic
DNA with GoTaq (Promega) using the following primers:
Kdm2b_forward, CCA GGA CAA GTA TGT AAA TAT
GGA GGG; Kdm2b_reverse, GTA CAA TTG TTT ATA
TAA ATC CAA CAA AGG TC; SmarcA4_forward,
ACC AGA CAT TCC TGA GTC CTG; SmarcA4_reverse,
CCA AGG CAA GTC CTA CTT ATT TAT TTC;
Dnmt3b_forward, TTC TAC CCA GGA CTG GGG
AGC; Dnmt3b_reverse, GAG AAA TAC AAC TTT AAT
CAA CCA GAA AGG. The products of amplification
(1035 bp for Kdm2b, 1262 bp for SmarcA4, and 1326 bp
for Dnmt3b) were cloned downstream of EGFP in a
pEGFPC1 expression vector (Addgene) and used in co-
transfection assays together with pDsRed-Express-C1
(Addgene) and mature miRNAs (miRIDIAN microRNA
Mimics, Dharmacon). Plasmid DNA and small RNA were
co-transfected using Xfect polymer and Xfect RNA trans-
fection reagents (Clontech), respectively, according to the
manufacturer’s instructions. E14 cells were plated in 12
multi-well plates (4 × 105/well) in ES cell medium 8 h
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before transfection. Cells were co-transfected in triplicate
with 50 pmol of mature miRNA, 0.5 μg of 3′ UTR/
pEGFPC1 vector or pEGFPC1 empty vector, and 0.5 μg of
pDsRed-Express-C1, which was used as an internal
reference of transfection. Both pEGFPC1 and pDsRed-
Express-C1 vectors carried a CMV promoter and
SV40_PA_terminator to drive constitutive expression.
Four hours after transfection, ES cell medium was re-
placed with CDMM (ELA cells) or new ES cell medium
(ES cells). EGFP and DsRed fluorescence was detected
by a GloMax®-Multi + Microplate Multimode Reader
(Promega) 48 h after transfection. The EGFP/DsRed
fluoresence ratio was compared among different samples
of transfected cells to evaluate the effect of the 3′ UTR on
EGFP translation.
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